Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Pregabalin on Colonic Motor and Sensory Function in Adults With Irritable Bowel Syndrome With Predominant Constipation

Next Previous
Trial Profile

Effect of Pregabalin on Colonic Motor and Sensory Function in Adults With Irritable Bowel Syndrome With Predominant Constipation

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Irritable bowel syndrome; Visceral pain
  • Focus Therapeutic Use

Most Recent Events

  • 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
  • 25 Jan 2013 New source identified and integrated (Mayo Clinic record: IRB11-000485).
  • 24 May 2012 Planned End Date changed from 1 Apr 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top